Medical device manufacturer Haemonetics (HAE -3.5%) gets hit after its FQ2 misses EPS estimates,...

|About: Haemonetics Corp (HAE)|By:, SA News Editor

Medical device manufacturer Haemonetics (HAE -3.5%) gets hit after its FQ2 misses EPS estimates, despite beating on revenue. Profits rose 8% Y/Y, but net income declined 35% due to quality issues with its HS Core Bowl and the recall of its OrthoPAT device.